Cargando…

Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway

Previous evidence suggested that astragaloside IV (ASIV) had a cardioprotective effect, but the potential mechanisms were undetermined. This study is aimed at validating the prevention of cardiac hypertrophy in chronic heart failure (CHF) rats and hypertrophy in H9c2 cardiomyocytes by ASIV and at ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Pei, Meng, Fanjing, Zhang, Jinguo, Wei, Xiqing, Shen, Cheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594267/ https://www.ncbi.nlm.nih.gov/pubmed/31285785 http://dx.doi.org/10.1155/2019/4625912

Ejemplares similares

Astragaloside IV attenuates ferroptosis after subarachnoid hemorrhage via Nrf2/HO-1 signaling pathway
por: Liu, Zhuanghua, et al.
Publicado: (2022)

The role of Nrf2 in astragaloside IV-mediated antioxidative protection on heart failure
por: Sui, Yan-Bo, et al.
Publicado: (2020)

Astragaloside IV alleviates heart failure by modulating Nrf-2
por: Feng, Wenxiao, et al.
Publicado: (2022)

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function
por: Sun, Chuang, et al.
Publicado: (2021)

Astragaloside IV alleviates stroke-triggered early brain injury by modulating neuroinflammation and ferroptosis via the Nrf2/HO-1 signaling pathway
por: Zhang, Chunlei, et al.
Publicado: (2023)

Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway
por: Zhang, Zhijie, et al.
Publicado: (2018)

Astragaloside IV Protects against Isoproterenol-Induced Cardiac Hypertrophy by Regulating NF-κB/PGC-1α Signaling Mediated Energy Biosynthesis
por: Zhang, Suping, et al.
Publicado: (2015)

Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy
por: Luo, Li-Fei, et al.
Publicado: (2021)

Review on the protective mechanism of astragaloside IV against cardiovascular diseases
por: Yang, Chunkun, et al.
Publicado: (2023)

Anticancer effects and mechanisms of astragaloside-IV
por: Zhou, Liangxing, et al.
Publicado: (2022)

Protective Effects of Astragaloside IV on db/db Mice with Diabetic Retinopathy
por: Ding, Yuzhi, et al.
Publicado: (2014)

Astragaloside IV protects RGC-5 cells against oxidative stress
por: Hao, Ming, et al.
Publicado: (2018)

Protective Effect of Astragaloside IV on Hepatic Injury Induced by Iron Overload
por: Xie, Dongyu, et al.
Publicado: (2019)

Astragaloside IV Attenuates Acetaminophen-Induced Liver Injuries in Mice by Activating the Nrf2 Signaling Pathway
por: Li, Lei, et al.
Publicado: (2018)

Astragaloside IV Exerts Cardioprotection in Animal Models of Viral Myocarditis: A Preclinical Systematic Review and Meta-Analysis
por: Zhuang, Zhuang, et al.
Publicado: (2019)

Therapeutic Effects of Astragaloside IV on Myocardial Injuries: Multi-Target Identification and Network Analysis
por: Zhao, Jing, et al.
Publicado: (2012)

Astragaloside IV protects against ischemia/reperfusion (I/R)-induced kidney injury based on the Keap1-Nrf2/ARE signaling pathway
por: Su, Yanyan, et al.
Publicado: (2022)

Effects of Astragaloside IV on heart failure in rats
por: Zhao, Zhuanyou, et al.
Publicado: (2009)

Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats
por: Liu, Wei, et al.
Publicado: (2019)

Astragaloside IV, as a potential anticancer agent
por: Xia, Dongqin, et al.
Publicado: (2023)

Pharmacological Effects of Astragaloside IV: A Review
por: Liang, Yutong, et al.
Publicado: (2023)

Xin-Ji-Er-Kang Alleviates Isoproterenol-Induced Myocardial Hypertrophy in Mice through the Nrf2/HO-1 Signaling Pathway
por: Yu, Ting-Ting, et al.
Publicado: (2022)

Identification of Hub Genes in Protective Effect of Astragaloside IV on Aconitine-Induced Cardiac Damage in Zebrafish Based on Bioinformatics Analysis
por: Wang, Mingzhu, et al.
Publicado: (2020)

A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury
por: Zheng, Qun, et al.
Publicado: (2018)

The Astragaloside IV Derivative LS-102 Ameliorates Obesity-Related Nephropathy
por: Li, Ziyu, et al.
Publicado: (2022)

Astragaloside IV Alleviates Tacrolimus-Induced Chronic Nephrotoxicity via p62-Keap1-Nrf2 Pathway
por: Gao, Ping, et al.
Publicado: (2021)

Astragaloside IV protects against apoptosis in human degenerative chondrocytes through autophagy activation
por: Liu, Jianhong, et al.
Publicado: (2017)

Protective effect of Astragaloside IV against sepsis-induced acute lung injury in rats
por: Huang, Ruiqin, et al.
Publicado: (2016)

Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
por: Zhang, Yudi, et al.
Publicado: (2020)

Research Progress on the Ability of Astragaloside IV to Protect the Brain Against Ischemia-Reperfusion Injury
por: Kang, Xianhui, et al.
Publicado: (2021)

Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury
por: Tang, Jia-Long, et al.
Publicado: (2022)

A Single, Acute Astragaloside IV Therapy Protects Cardiomyocyte Through Attenuating Superoxide Anion-Mediated Accumulation of Autophagosomes in Myocardial Ischemia-Reperfusion Injury
por: Huang, Kai-yu, et al.
Publicado: (2021)

Scutellarin Exerts Hypoglycemic and Renal Protective Effects in db/db Mice via the Nrf2/HO-1 Signaling Pathway
por: Liu, Yange, et al.
Publicado: (2019)

BRD4 Silencing Protects Angiotensin II-Induced Cardiac Hypertrophy by Inhibiting TLR4/NF-κB and Activating Nrf2-HO-1 Pathways
por: Fang, Ming, et al.
Publicado: (2022)

The mechanism of astragaloside IV promoting sciatic nerve regeneration
por: Zhang, Xiaohong, et al.
Publicado: (2013)

Astragaloside IV: An Effective Drug for the Treatment of Cardiovascular Diseases
por: Tan, Yu-Qing, et al.
Publicado: (2020)

Molecular mechanisms of astragaloside-IV in cancer therapy (Review)
por: Chen, Tianqi, et al.
Publicado: (2021)

Roles and Mechanisms of Astragaloside IV in Combating Neuronal Aging
por: Zaman, Qumar, et al.
Publicado: (2022)

Research progress on the mechanism of astragaloside IV in the treatment of asthma
por: Yuan, Fanyi, et al.
Publicado: (2023)

Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism
por: Zhang, Zhen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dcnc22sp701ks80nqks9n3qkvj